Sarepta Therapeutics (SRPT) has caught the attention of investors after shares rose nearly 2% in recent trading. The move comes as the biotech sector shows mixed results and puts a spotlight on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback